ProFunds Biotechnology UltraSector Fund Service Class logo

ProFunds Biotechnology UltraSector Fund Service Class (BIPSX)

Market Closed
10 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
49. 22
+0.29
+0.5927%
$
190.64M Market Cap
- Div Yield
0 Volume
$ 48.93
Previous Close
Add Transaction
Day Range
49.22 49.22
Year Range
20.79 52.47
Want to track BIPSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BIPSX closed today higher at $49.22, an increase of 0.5927% from yesterday's close, completing a monthly increase of 0.7162% or $0.35. Over the past 12 months, BIPSX stock gained 41.8444%.
BIPSX pays dividends to its shareholders, with the most recent payment made on Dec 22, 2025. The next estimated payment will be in In 4 months on Dec 22, 2026 for a total of $0.01967.
ProFunds Biotechnology UltraSector Fund Service Class has completed 2 stock splits, with the recent split occurring on Feb 24, 2014.
The company's stock is traded on one exchange.

BIPSX Chart

ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) FAQ

What is the stock price today?

The current price is $49.22.

On which exchange is it traded?

ProFunds Biotechnology UltraSector Fund Service Class is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is BIPSX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 190.64M.

Has ProFunds Biotechnology UltraSector Fund Service Class ever had a stock split?

ProFunds Biotechnology UltraSector Fund Service Class had 2 splits and the recent split was on Feb 24, 2014.

ProFunds Biotechnology UltraSector Fund Service Class Profile

NASDAQ (NMS) Exchange
US Country

Overview

The fund is designed for investors looking for exposure to the biotechnology sector of the stock market. It operates by investing in financial instruments that its advisors believe will, in combination, help achieve daily returns consistent with the fund's Daily Target. The specific focus is on the biotechnology segment of the S&P Total Market Index, which encompasses a range of companies within the biotech sub-industry. This investment approach highlights the fund's commitment to targeting potentially high-growth opportunities within the biotechnology field. Notably, the fund is non-diversified, meaning it may invest a larger percentage of its assets in fewer stocks, potentially leading to higher volatility and risk, as well as the possibility of higher returns.

Products and Services

  • Daily Target Return Investments:

The primary service offered by the fund is its focus on achieving returns that align with a pre-set daily target. This is carried out through strategic investments in financial instruments related to the biotechnology sector. By aiming for daily target returns, the fund seeks to provide a unique investment opportunity for investors interested in the dynamic biotechnology market.

  • Biotechnology Sector Exposure:

Through its investment strategy, the fund provides investors with exposure to the biotechnology segment of the S&P Total Market Index. This encompasses a variety of biotech companies, allowing investors to tap into the growth potential of this innovative and rapidly evolving sector. The focus on a single, high-growth industry segment is intended to offer investors the opportunity for significant returns, albeit with a higher risk profile compared to more diversified funds.

Contact Information

Address: 7272 Wisconsin Avenue
Phone: 2404976428